CervoMed Inc reports results for the quarter ended September 30 - Earnings Summary

CervoMed

12/11/2024 13:38

* CervoMed Inc  CRVO.OQ  reported a quarterly adjusted loss
of 55
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -70 cents.  The mean expectation of five analysts for the
quarter was for a loss of 41 cents per share. Wall Street
expected results to range from -50 cents to -31 cents per share.
    * Revenue rose 27.1% to $1.94 million from a year ago;
analysts
expected $3.07 million. 
    * CervoMed Inc's reported EPS for the quarter was a loss
of 55
cents​.
    * The company reported a quarterly loss of $4.75 million.
    * CervoMed Inc shares had fallen by 16.8% this quarter and
gained 59.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 8.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CervoMed Inc is
63.00 
This summary was machine generated from LSEG data November 12 at
01:38 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.41          -0.55          Missed
 Jun. 30 2024      -0.31          -0.27          Beat
 Mar. 31 2024      -0.39          -0.41          Missed
 Dec. 31 2023      -0.29          -0.38          Missed